SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-106580
Filing Date
2013-03-14
Accepted
2013-03-14 11:27:19
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d451807d10k.htm 10-K 1091512
2 EX-23.1 d451807dex231.htm EX-23.1 1482
3 EX-31.1 d451807dex311.htm EX-31.1 9377
4 EX-31.2 d451807dex312.htm EX-31.2 9374
5 EX-32.1 d451807dex321.htm EX-32.1 2621
6 EX-32.2 d451807dex322.htm EX-32.2 2791
13 GRAPHIC g451807g03r13.jpg GRAPHIC 110562
14 GRAPHIC g451807g11t72.jpg GRAPHIC 61340
  Complete submission text file 0001193125-13-106580.txt   6652617

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT clvs-20121231.xml EX-101.INS 857133
8 XBRL TAXONOMY EXTENSION SCHEMA clvs-20121231.xsd EX-101.SCH 70908
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20121231_cal.xml EX-101.CAL 74492
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20121231_def.xml EX-101.DEF 349228
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20121231_lab.xml EX-101.LAB 485282
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20121231_pre.xml EX-101.PRE 407111
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 13689566
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences